Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review

This publication has 39 references indexed in Scilit:

• Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
  The Oncologist, 2014
• First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patients
  Annals of Oncology, 2013
• The role of PARP in DNA repair and its therapeutic exploitation
  British Journal of Cancer, 2011
• The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
  Molecular Oncology, 2011
• Pattern of metastatic spread in triple-negative breast cancer
  Breast Cancer Research and Treatment, 2008
• Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
  Journal of Clinical Oncology, 2008
• Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
  Clinical Cancer Research, 2007
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
  Nature, 2005
• Hallmarks of 'BRCAness' in sporadic cancers
  Nature Reviews Cancer, 2004
• Medical Assessment by a Delphi Group Opinion Technic
  New England Journal of Medicine, 1973